Preoperative serum levels of wild-type and hepatitis B e antigen-negative Hepatitis B Virus (HBV) and graft infection after liver transplantation for HBV-related hepatocellular carcinoma

Journal of Viral Hepatitis

Volumn 4, Issue 4, 1997, Pages 235-242

  Mazzaferro, V ^a   Brunetto, M R ^b   Pasquali, M ^a   Regalia, E ^a   Pulvirenti, A ^a   Baratti, D ^a   Makowka, L ^c   Van Thiel, D ^d   Bonino, F ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b MOLINETTE HOSPITAL   (Italy)

^c ST VINCENT MEDICAL CENTER   (United States)

^d UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

Author keywords

HBV DNA; Hepatitis B virus; Hepatocellular carcinoma; Orthotopic liver transplantation; PCR; Precore heterogeneity; Viral hepatitis

Indexed keywords

ALPHA2B INTERFERON; HEPATITIS B ANTIBODY; HEPATITIS B ANTIGEN; VIRUS DNA;

AGED; ARTICLE; BLOOD; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HETEROZYGOTE; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LIVER; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LIVER TUMOR; MALE; MIDDLE AGED; PASSIVE IMMUNIZATION; PILOT STUDY; VIREMIA; VIROLOGY;

AGED; CARCINOMA, HEPATOCELLULAR; CARRIER STATE; DNA, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNIZATION, PASSIVE; INTERFERON ALFA-2B; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PILOT PROJECTS; VIREMIA;

EID: 0031180735     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.1997.00057.x     Document Type: Article

References (23)

1. Todo S, Demetris AJ, Van Thiel DH, Teperman L, Fung JJ, Starzl TE. Orthotopic liver transplant for patients with hepatitis B virus (HBV)-related liver disease. Hepatology 1991; 13: 619-626.
2. O'Grady JG, Smith HM, Davies S et al. Hepatitis B virus reinfection after orthotopic liver transplant. J Hepatol 1992; 14: 104-111.
3. Freeman RB, Sanchez H, Lewis WD et al. Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplant. Transplant 1991; 51: 793-797.
4. Samuel D, Bismuth A, Mathieu D et al. Passive immunoprophylaxis after liver transplant in HBsAg-positive patients. Lancet 1991; 337: 813-815.
5. Muller R, Gubernatis G, Farle M et al. Liver transplant in HBsAg carriers. Prevention of hepatitis B virus recurrence by passive immunisation. J Hepatol 1991; 13: 90-96.
6. Samuel D, Muller R, Alexander GJM et al. and the Investigators of the European Concerted Action on Viral Hepatitis Study. Liver transplant in European patients with hepatitis B surface antigen. N Engl J Med 1993; 316: 1842-1847.
7. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699.
8. Dusheiko G, Hoofnagle JH. Hepatitis B. In: McIntyre N, Benhamou JP, Bircher J, Rizzetto M, Rodes J, eds. Oxford Textbook of Clinical Hepatology. Oxford: Oxford University Press 1991: 571-592.
9. Carman W, Thomas H, Domingo E. Viral genetic variation: hepatitis B virus as a clinical example. Lancet 1993; 341: 349-353.
10. Brunetto MR, Stemler M, Schodel F et al. Identification of HBV variants which cannot produce precore derived HBeAg and may be responsible for severe hepatitis. Ital J Gastroenterol 1989; 21: 151-154.
11. Bonino F, Brunetto MR, Rizzetto M, Will H. Hepatitis B virus unable to secrete e antigen. Gastroenterology 1991; 100: 1138-1141.
12. Omata M, Ehata T, Yokysuda O, Hosoda K, Ohto M. Mutation in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis. N Engl J Med 1991; 324: 1699-1704.
13. Brunetto MR, Giarin M, Oliveri F et al. 'e' antigen defective hepatitis B virus and course of chronic infection. J Hepatol 1991; 13: S92-S96.
14. Carman WF, Jacyna MR, Hadziyannis S et al. Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection. Lancet 1989; 334: 588-591.
15. Wright TL, Lau JYN. Clinical aspects of hepatitis B virus infection. Lancet 1993; 342: 1340-1344.
16. Brunetto MR, Giarin MM, Oliveri F et al. Wild-type and e antigen-minus hepatitis B virus and course of chronic hepatitis. Proc Natl Acad Sci USA 1991; 88: 4186-4190.
17. Davies SE, Portmann BC, O'Grady JG et al. Hepatic histological findings after transplant for chronic hepatitis B virus infection, including a unique pattern of fibrosis cholestatic hepatitis. Hepatology 1991; 13: 150-157.
18. Fang JWS, Tung FYT, Davis GL, Dolson DJ, Van Thiel DH, Lau JYN. Fibrosing cholestatic hepatitis in a transplant recipient with hepatitis B virus pre-core mutant. Gastroenterology 1993; 105: 901-904.
19. Okamoto H, Yotsumoto S, Akahane Y et al. Hepatitis B viruses with precore region defects prevail in persistent infected hosts along with seroconversion to the antibody against e antigen. J Virol 1990; 64: 1298-1303.
20. Terazawa S, Kojima M. Yamanaka T et al. Hepatitis B virus mutants with precore region defects in two babies with fulminant hepatitis and their mothers positive for the antibody to hepatitis B e antigen. Pediatr Res 1991; 29: 5-9.
21. Brunetto MR, Oliveri F, Demartini A et al. Treatment with interferon of chronic hepatitis B associated with antibody to hepatitis B e antigen. J Hepatol 1991; 13: S8-S11.
22. Hadziyannis S, Bramou T, Makris A, Moussoulis G, Zigneg L, Papaioannou C. Interferon alfa-2b treatment of HBeAg neg./serum HBV-DNA pos. chronic hepatitis type B. J Hepatol 1990; 11: 8133-8136.
23. Fattovich G, Farci P, Rugge M et al. A randomized controlled trial of lymphoblastoid interferon-alpha in patients with chronic hepatitis B lacking HBeAg. Hepatology 1992; 15: 584-589.